A randomised, ciprofloxacin-controlled study of two prulifloxacin regimens in antibiotic prophylaxis for transrectal prostatic biopsy TPB .

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-002888-88-IT

Enrollment

135

Registered

2007-01-22

Start date

2006-02-22

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antibiotic prophylaxis for transrectal prostatic biopsy

Interventions

Trade Name: J01MA17 - PRULIFLOXACINA PRULIFLOXACINA UNIDROX*5CPR RIV 600MG Product Code: J01MA17 Pharmaceutical Form: Tablet INN or Proposed INN: Prulifloxacin Current Sponsor code: 027SC05013 Conc

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026